Bristol Myers Squibb CDTO Greg Meyers on biopharma’s AI-enabled future
Eureka!
Nov 5
30 min
Greg Meyers, Executive Vice President and Chief Digital & Technology Officer at Bristol Myers Squibb (BMS) discusses how technology can be leveraged to drive outcomes.See www.mckinsey.com/privacy-policy for privacy information
See all episodes
More episodes like this
Transforming Healthcare with Responsible AI: A Conversation with David Rhew, Microsoft’s Global Chief Medical Officer
How CytoReason is Bridging the Data Insight Gap to Accelerate Healthcare Breakthroughs - Ep. 276
Rethinking Clinical Trial Operations with AI and Remote Monitoring - with Scott Bradley of Novartis
Isomorphic Labs Discusses AI-Driven Drug Discovery and the Future of Medicine - Ep. 252
AI for Drug Discovery
AI Use Case Series: AI in Pharma [AI Today Podcast]
Home
Search
Your Library
Premium
,
